Prostanoid IP receptor — Drug Target

All drugs that target Prostanoid IP receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Prostacyclin analog / IP receptor agonist · Prostanoid IP receptor agonist

Phase 3 pipeline (2)

• ONO-8025 (KRP-197) · Ono Pharmaceutical Co. Ltd · Prostacyclin analog / IP receptor agonist · Cardiovascular
  ONO-8025 is a selective prostanoid receptor agonist that activates IP receptors to promote vasodilation and inhibit platelet aggregation.
• ONO-5920 · Ono Pharmaceutical Co. Ltd · Prostanoid IP receptor agonist · Cardiovascular
  ONO-5920 is a selective prostanoid receptor agonist that activates IP receptors to promote vasodilation and inhibit platelet aggregation.